Authors: Kristoferitsch, W Seeldrayers, P Kyriallis, K Brochet, B Confavreux, C Clanet, M Cesaro, P Defer, G Edan, G Lyon-Caen, O Pelletier, J Rumbach, L Roullet, E Vermersch, P Dengler, R Zschenderlein, R Storch-Hagenlocher, B Sailer, M Hohlfeld, R Kunze, KP Heesen, C Bamborschke, P Grunwald, F Hartung, HP Rieckmann, P DeKeyser, J Montalban, X Fernandez, U Arbizu, T Sandberg, M Kappos, L Bates, D Campbell, MJ Capildeo, R Compston, A McLellan, DL Wroe, S Young, C Clanet, M Hartung, HP Hohlfeld, R Kappos, L Radue, EW Rieckmann, P Sandberg, M Polman, C Kesselring, J Thompson, A Wekerle, H Whitehead, J Bains, H Butler, E Kooijmans-Coutinho, M McAllister, A Simonian, N White, K Anderson, D Liddiard, S Keane, R

Citation: W. Kristoferitsch et al., Double-blind randomized multicenter dose-comparison study of interferon-beta-1a (AVONEX): rationale, design and baseline data, MULT SCLER, 7(3), 2001, pp. 179-183

Authors: Alf, C Bancher, C Berger, O Binder, H Brucke, T Deecke, L Domanovits, H Donis, J Catterbauer, E Glawar, B Grisold, W Heimberger, K Hirschl, M Hoberstorfer, M Kaff, A Kristoferitsch, W Laggner, A Lalouschek, W Lang, W Lassmann, J Mamoli, B Pankl, W Parigger, S Podreka, I Prainer, C Schlager, T Schlederer, M Schmidbauer, M Schnaberth, G Segall, B

Citation: C. Alf et al., The Vienna Stroke Registry - Objectives and methodology, WIEN KLIN W, 113(3-4), 2001, pp. 141-147

Authors: Fazekas, F Strasser-Fuchs, S Kollegger, H Berger, T Kristoferitsch, W Schmidt, H Enzinger, C Schiefermeier, M Schwarz, C Kornek, B Reindl, M Huber, K Grass, R Wimmer, G Vass, K Pfeiffer, KH Hartung, HP Schmidt, R

Citation: F. Fazekas et al., Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosis, NEUROLOGY, 57(5), 2001, pp. 853-857

Authors: Buttner, U Chofflon, M Hess, K Kappos, L Kesselring, J Ludin, HP Schluep, M Vaney, C Baumhackl, U Berger, T Deisenhammer, F Freimuller, M Hartung, HP Kollegger, H Kristoferitsch, W Lassmann, H Markut, H Vass, K Altenkirch, H Boese, J Gass, A Gehlen, W Goebels, N Haas, J Haferkamp, G Heidenreich, F Heitmann, R Hemmer, B Hohlfeld, R Janzen, RWC Jugelt, E Kolmel, W Konig, N Kowitzsch, K Manegold, U Melms, A Mertin, J Petereit, HF Pette, M Pohlau, D Poser, S Sailer, M Schmidt, S Schock, G Schulz, M Seidel, D Stangel, M Stark, E Stoll, G Weinrich, W Wietholter, H Zettl, UK Zipp, F Zschenderlein, R Bayas, A Chan, A Flachenecker, P Gold, R Grauer, O Jung, S Kallmann, B Leussink, V Maurer, M Rieckmann, P Toyka, KV Weilbach, FX

Citation: U. Buttner et al., Escalating immunomodulatory therapy of multiple sclerosis - 1. Supplement, NERVENARZT, 72(2), 2001, pp. 150-157

Authors: Buttner, U Chofflon, M Hess, K Kappos, L Kesselring, J Ludin, H Rihs, F Schluep, M Vaney, C Baumhackl, U Berger, T Freimuller, O Hartung, HP Kollegger, W Kristoferitsch, W Vass, K Lassmann, H Markut, S Altenkirch, H Boese, J Gehlen, W Goebels, N Gold, R Haas, J Haferkamp, G Heidenreic, F Heitmann, R Hohlfeld, R Jugelt, E Kolmel, H Konig, N Lowitzsch, K Manegold, U Mertin, J Pette, M Poser, S Sailer, J Schack, G Schulz, M Seidel, D Stark, E Stoll, G Weinrich, W Wietholter, H Zettl, U Zipp, F Zschenderlein, R Rieckmann, P Toyka, KV Chan, A Bayas, A Maurer, M Jung, S Gold, R Weilbach, F Cursiefen, S Flachenecker, P Rieckmann, P

Citation: U. Buttner et al., Escalating immunomodulatory therapy of multiple sclerosis, NERVENARZT, 70(4), 1999, pp. 371-386